Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients.

Posa D, Martínez-González L, Bartolomé F, Nagaraj S, Porras G, Martínez A, Martín-Requero Á.

Mol Neurobiol. 2018 Jul 20. doi: 10.1007/s12035-018-1249-8. [Epub ahead of print]

PMID:
30030753
2.

Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Del Cerro P, Alquézar C, Bartolomé F, González-Naranjo P, Pérez C, Carro E, Páez JA, Campillo NE, Martín-Requero Á.

CNS Drugs. 2018 May 7. doi: 10.1007/s40263-018-0515-7. [Epub ahead of print]

PMID:
29736745
3.

Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer's Disease.

González-Sánchez M, Díaz T, Pascual C, Antequera D, Herrero-San Martín A, Llamas-Velasco S, Villarejo-Galende A, Bartolome F, Carro E.

Mol Neurobiol. 2018 Mar 30. doi: 10.1007/s12035-018-1039-3. [Epub ahead of print]

PMID:
29603091
4.

Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Ber IL, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2018 Mar 1;8(1):4064. doi: 10.1038/s41598-018-22152-9.

5.

Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition.

Bartolome F, de la Cueva M, Pascual C, Antequera D, Fernandez T, Gil C, Martinez A, Carro E.

Alzheimers Res Ther. 2018 Feb 20;10(1):24. doi: 10.1186/s13195-018-0352-4.

6.

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.

Carro E, Bartolomé F, Bermejo-Pareja F, Villarejo-Galende A, Molina JA, Ortiz P, Calero M, Rabano A, Cantero JL, Orive G.

Alzheimers Dement (Amst). 2017 May 26;8:131-138. doi: 10.1016/j.dadm.2017.04.002. eCollection 2017.

7.

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Le Ber I, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2017 May 10;7(1):1666. doi: 10.1038/s41598-017-01678-4. Erratum in: Sci Rep. 2018 Mar 1;8(1):4064.

8.

Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons.

Ludtmann MHR, Arber C, Bartolome F, de Vicente M, Preza E, Carro E, Houlden H, Gandhi S, Wray S, Abramov AY.

J Biol Chem. 2017 May 26;292(21):8907-8917. doi: 10.1074/jbc.M116.762898. Epub 2017 Mar 30.

9.

Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin.

Bartolome F, Antequera D, Tavares E, Pascual C, Maldonado R, Camins A, Carro E.

J Neuroinflammation. 2017 Jan 31;14(1):26. doi: 10.1186/s12974-017-0800-2.

10.

L2,3-edges absorption spectra of a 2D complex system: a theoretical modelling.

Carlotto S, Sambi M, Sedona F, Vittadini A, Bartolomé J, Bartolomé F, Casarin M.

Phys Chem Chem Phys. 2016 Oct 12;18(40):28110-28116.

PMID:
27722572
11.

Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction.

Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, Pope S, Cochemé HM, Khan S, Asghari S, Bhatia KP, Hardy J, Abramov AY, Partridge L.

Brain. 2015 Jul;138(Pt 7):1801-16. doi: 10.1093/brain/awv132. Epub 2015 May 22.

12.

Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease.

Alquézar C, Barrio E, Esteras N, de la Encarnación A, Bartolomé F, Molina JA, Martín-Requero Á.

J Neurochem. 2015 Jun;133(6):886-97. doi: 10.1111/jnc.13070. Epub 2015 Mar 15.

13.

Measurement of mitochondrial NADH and FAD autofluorescence in live cells.

Bartolomé F, Abramov AY.

Methods Mol Biol. 2015;1264:263-70. doi: 10.1007/978-1-4939-2257-4_23.

PMID:
25631020
14.

G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients.

Esteras N, Alquézar C, Bartolomé F, de la Encarnación A, Bermejo-Pareja F, Molina JA, Martín-Requero Á.

Mol Neurobiol. 2015 Aug;52(1):386-98. doi: 10.1007/s12035-014-8870-y. Epub 2014 Sep 3.

PMID:
25182869
15.

High-resolution imaging of remanent state and magnetization reversal of superdomain structures in high-density cobalt antidot arrays.

Rodríguez LA, Magén C, Snoeck E, Gatel C, Castán-Guerrero C, Sesé J, García LM, Herrero-Albillos J, Bartolomé J, Bartolomé F, Ibarra MR.

Nanotechnology. 2014 Sep 26;25(38):385703. doi: 10.1088/0957-4484/25/38/385703. Epub 2014 Sep 2.

PMID:
25181396
16.

Large orbital magnetic moment in Pt₁₃ clusters.

Bunău O, Bartolomé J, Bartolomé F, Garcia LM.

J Phys Condens Matter. 2014 May 14;26(19):196006. Epub 2014 Apr 24.

PMID:
24883454
17.

Parimagnetism in HoCo2 and TmCo2.

Bonilla CM, Herrero-Albillos J, Figueroa AI, Castán-Guerrero C, Bartolomé J, Calvo-Almazán I, Schmitz D, Weschke E, García LM, Bartolomé F.

J Phys Condens Matter. 2014 Apr 16;26(15):156001. doi: 10.1088/0953-8984/26/15/156001. Epub 2014 Mar 27.

PMID:
24675016
18.

Multiferroic (ferroelastic/ferromagnetic/ferrimagnetic) aspects of phase transitions in RCo2 Laves phases.

Driver SL, Herrero-Albillos J, Bonilla CM, Bartolomé F, García LM, Howard CJ, Carpenter MA.

J Phys Condens Matter. 2014 Feb 5;26(5):056001. doi: 10.1088/0953-8984/26/5/056001. Epub 2014 Jan 17.

PMID:
24441049
19.

SiO2 coating effects in the magnetic anisotropy of Fe3-xO4 nanoparticles suitable for bio-applications.

Figueroa AI, Moya C, Bartolomé J, Bartolomé F, García LM, Pérez N, Labarta A, Batlle X.

Nanotechnology. 2013 Apr 19;24(15):155705. doi: 10.1088/0957-4484/24/15/155705. Epub 2013 Mar 22.

PMID:
23518930
20.

Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.

Bartolome F, Wu HC, Burchell VS, Preza E, Wray S, Mahoney CJ, Fox NC, Calvo A, Canosa A, Moglia C, Mandrioli J, Chiò A, Orrell RW, Houlden H, Hardy J, Abramov AY, Plun-Favreau H.

Neuron. 2013 Apr 10;78(1):57-64. doi: 10.1016/j.neuron.2013.02.028. Epub 2013 Mar 14.

21.

Strong paramagnetism of gold nanoparticles deposited on a Sulfolobus acidocaldarius S layer.

Bartolomé J, Bartolomé F, García LM, Figueroa AI, Repollés A, Martínez-Pérez MJ, Luis F, Magén C, Selenska-Pobell S, Pobell F, Reitz T, Schönemann R, Herrmannsdörfer T, Merroun M, Geissler A, Wilhelm F, Rogalev A.

Phys Rev Lett. 2012 Dec 14;109(24):247203. Epub 2012 Dec 10.

PMID:
23368371
22.

Fabrication and magnetic characterization of cobalt antidot arrays: effect of the surrounding continuous film.

Castán-Guerrero C, Sesé J, Bartolomé J, Bartolomé F, Herrero-Albillos J, Kronast F, Strichovanec P, Merazzo KJ, Vázquez M, Vavassori P, García LM.

J Nanosci Nanotechnol. 2012 Sep;12(9):7437-41.

PMID:
23035490
23.

Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].

Esteras N, Bartolomé F, Alquézar C, Antequera D, Muñoz Ú, Carro E, Martín-Requero Á.

Eur J Neurosci. 2012 Sep;36(5):2609-18. doi: 10.1111/j.1460-9568.2012.08178.x. Epub 2012 Jun 15.

PMID:
22702220
24.

Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).

Esteras N, Alquézar C, Bartolomé F, Antequera D, Barrios L, Carro E, Cerdán S, Martín-Requero A.

J Alzheimers Dis. 2012;30(2):337-53. doi: 10.3233/JAD-2012-111967.

PMID:
22406445
25.

Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients.

Esteras N, Muñoz Ú, Alquézar C, Bartolomé F, Bermejo-Pareja F, Martín-Requero Á.

Curr Alzheimer Res. 2012 Mar;9(3):267-77.

26.

Evolution of Fe magnetic order in NdFexGa ₁- xO₃.

Parra-Borderías M, Bartolomé F, Velamazán JA, Bartolomé J.

J Phys Condens Matter. 2011 Feb 2;23(4):046003. doi: 10.1088/0953-8984/23/4/046003. Epub 2011 Jan 12.

PMID:
21406898
27.

Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia.

Alquezar C, Esteras N, Bartolomé F, Merino JJ, Alzualde A, López de Munain A, Martín-Requero Á.

Neurobiol Aging. 2012 Feb;33(2):429.e7-20. doi: 10.1016/j.neurobiolaging.2010.11.020. Epub 2011 Jan 12.

PMID:
21232819
28.

Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer's disease patients.

Bartolomé F, Muñoz U, Esteras N, Alquezar C, Collado A, Bermejo-Pareja F, Martín-Requero A.

Cell Mol Life Sci. 2010 Dec;67(24):4257-68. doi: 10.1007/s00018-010-0443-2. Epub 2010 Jul 8.

PMID:
20614159
29.

[How to identify adverse events in emergency services? A guide agreed for the screening].

Requena J, Aranaz JM, Mira JJ, Gea MT, Miralles JJ, Limón R, Rey M, Carrasco M, Lerma M, López J, García S, Gómez N, Puy AI, Bartolomé F, Pardo S, Ziadi M, Tomas O, Guilabert M.

Rev Calid Asist. 2009 Nov-Dec;24(6):272-9. doi: 10.1016/j.cali.2009.06.002. Epub 2009 Sep 5. Spanish.

PMID:
19761743
30.

Observation of a Griffiths-like phase in the paramagnetic regime of ErCo(2).

Herrero-Albillos J, García LM, Bartolomé F.

J Phys Condens Matter. 2009 May 27;21(21):216004. doi: 10.1088/0953-8984/21/21/216004. Epub 2009 Apr 29.

PMID:
21825569
31.

Distinct regulation of cell cycle and survival in lymphocytes from patients with Alzheimer's disease and amyotrophic lateral sclerosis.

Bartolomé F, Muñoz U, Esteras N, Esteban J, Bermejo-Pareja F, Martín-Requero A.

Int J Clin Exp Pathol. 2009;2(4):390-8. Epub 2008 Dec 1.

32.

Surface anisotropy broadening of the energy barrier distribution in magnetic nanoparticles.

Pérez N, Guardia P, Roca AG, Morales MP, Serna CJ, Iglesias O, Bartolomé F, García LM, Batlle X, Labarta A.

Nanotechnology. 2008 Nov 26;19(47):475704. doi: 10.1088/0957-4484/19/47/475704. Epub 2008 Oct 30.

PMID:
21836285
33.

On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.

Muñoz U, Bartolomé F, Esteras N, Bermejo-Pareja F, Martín-Requero A.

Cell Mol Life Sci. 2008 Nov;65(21):3507-19. doi: 10.1007/s00018-008-8411-9.

PMID:
18818877
34.

[Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome].

Pérez ER, Bartolomé FB, Carretero PS, Fernández CS, Mateos EJ, Tarlovsky LG.

Rev Esp Anestesiol Reanim. 2008 Jan;55(1):26-31. Spanish.

PMID:
18333383
35.
36.

Impaired apoptosis in lymphoblasts from Alzheimer's disease patients: cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways.

Bartolomé F, de Las Cuevas N, Muñoz U, Bermejo F, Martín-Requero A.

Cell Mol Life Sci. 2007 Jun;64(11):1437-48.

PMID:
17502994
37.

Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.

Muñoz U, Bartolomé F, Bermejo F, Martín-Requero A.

Neurobiol Aging. 2008 Oct;29(10):1474-84. Epub 2007 Apr 19.

PMID:
17448572
38.
39.

[Primary focal dystonia: descriptive study of 205 patients].

Bartolomé FM, Fanjul S, Cantarero S, Hernández J, García Ruiz PJ.

Neurologia. 2003 Mar;18(2):59-65. Spanish.

PMID:
12610754
40.

Orbital magnetic moment instability at the spin reorientation transition of Nd2Fe14B

Garcia LM, Chaboy J, Bartolome F, Goedkoop JB.

Phys Rev Lett. 2000 Jul 10;85(2):429-32.

PMID:
10991300
41.

[Anterograde decremental conduction by left free wall accessory pathway in the permanent form of junctional reciprocating tachycardia].

Bartolomé FB, Sánchez Fernández-Bernal C, Torres Feced V.

Rev Esp Cardiol. 2000 Jun;53(6):878-80. Spanish.

42.

[Radiofrequency catheter ablation of supraventricular tachycardia in an adult with corrected tetralogy of Fallot].

Bartolomé FB, Sánchez Fernández-Bernal C.

Rev Esp Cardiol. 1998 Nov;51(11):918-21. Spanish.

43.

[Radiofrequency catheter ablation of accessory pathways in an infant tuberous sclerosis and cardiac rhabdomyoma].

Bartolomé FB, Sánchez Fernández-Bernal C.

Rev Esp Cardiol. 1998 Mar;51(3):255-7. Spanish.

44.

[Idiopathic left ventricular tachycardia in infancy: long-term control with verapamil].

Bartolomé FB, Sánchez Fernández-Bernal C.

Rev Esp Cardiol. 1998 Mar;51(3):252-4. Spanish.

45.

Effect of Chiral Domain Walls on the Specific Heat of Gd(hfac)3NITR (R=Ethyl,Isopropyl,Methyl,Phenyl) Molecular Magnetic Chains.

Bartolomé F, Bartolomé J, Benelli C, Caneschi A, Gatteschi D, Paulsen C, Pini MG, Rettori A, Sessoli R, Volokitin Y.

Phys Rev Lett. 1996 Jul 8;77(2):382-385. No abstract available.

PMID:
10062437
46.

Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study.

Carreño V, Moreno A, Galiana F, Bartolomé FJ.

J Hepatol. 1993 Mar;17(3):321-5.

PMID:
8315260
47.

[Reactivation of hepatitis B virus in chronic carriers with anti-HBe].

Porres JC, Carreño V, Moreno A, Bartolomé FJ.

Rev Clin Esp. 1991 Jun;189(2):68-72. Spanish.

PMID:
1784780
48.

[A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].

Carreño V, Porres JC, Ruiz-Moreno M, Gutiez J, Bartolomé FJ.

Rev Esp Enferm Dig. 1991 Jan;79(1):24-8. Spanish.

PMID:
2031770
49.
50.

Changes in anti-idiotype antibodies against anti-HBs during recombinant interferon treatment of chronic hepatitis B.

Ibarra MZ, Porres JC, Bartolome FJ, Escudero M, Quiroga JA, Carreño V.

J Interferon Res. 1990 Aug;10(4):367-73.

PMID:
2230344

Supplemental Content

Loading ...
Support Center